HIV and HCV Intervention In Drug Treatment Settings - 1
NCT ID: NCT00102349
Last Updated: 2017-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
706 participants
INTERVENTIONAL
2004-11-30
2006-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motivational Interviewing to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
NCT00032994
Chronic Hepatitis Intervention Project for Drug Users
NCT00596843
Motivational Enhancement to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse - 1
NCT00032981
Intervention to Reduce Injection Drug Use
NCT00786630
Comparing Brief Alcohol Interventions For HIV-HCV Co-infected Persons
NCT02316184
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PREVENTION
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behavior Therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oregon Health and Science University
OTHER
University of Colorado, Denver
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Colorado at Denver
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Booth, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Colorado, Denver
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver Health & Hosp Authority
Denver, Colorado, United States
Island Grove RTC
Greeley, Colorado, United States
SSTAR (Stanley St. Treatment & Resources, Inc)
Fall River, Massachusetts, United States
James Gilmore Jr. Treatment Center
Kalamazoo, Michigan, United States
Willamette Family Treatment Services
Eugene, Oregon, United States
SSTAR of Rhode Island - North Kingstown
North Kingstown, Rhode Island, United States
Recovery Center King Co.-Kent Detox
Kent, Washington, United States
Recovery Center King Co.-Seattle Detox
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIDA-CTN-0017-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.